Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
RNA binding proteins are characterized as a new family of apoptosis inducers; however, the mechanism by which they induce apoptosis is poorly understood. KHDC1 family members were recently identified as K-homology (KH)-domain containing RNA binding proteins that are unique to eutherian mammals and highly expressed in oocytes. In this study, we report that the expression of
KHDC1A
induces
caspase-3
dependent apoptosis and inhibits mRNA translation, and the translational repression is independent of apoptosis. We demonstrate that both the N-terminus and C-terminus of
KHDC1A
are required for its pro-apoptotic and translational repression activities. Furthermore, in the C-terminus of
KHDC1A
, a putative trans-membrane motif (TMM) is critical for these activities. In addition, the ectopically expressed
KHDC1A
is localized to the endoplasmic reticulum (ER) and changes the morphology of the ER. The inhibition of ER-specific caspase-12 successfully rescues
KHDC1A
-induced apoptosis, but not Fas-induced apoptosis. Taken together, we conclude that
KHDC1A
functions as a global translational repressor and induces apoptosis through an ER-dependent signaling pathway.
...
PMID:KHDC1A, a novel translational repressor, induces endoplasmic reticulum-dependent apoptosis. 2273 19